neobookRx

Glomerular Disease and Nephritic Syndrome

Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Adults 2019 Edition

Description

General measures

Medicine treatment

Consultation/referral


N04.9/N05.9

DESCRIPTION

Acute glomerulonephritis presents with one or more of the following: haematuria, proteinuria, an acute decrease in eGFR, fluid retention,  or hypertension.

GENERAL MEASURES

  • Give oxygen, and place patient in semi-Fowlers position if patient has respiratory distress.
  • Early consultation with a specialist.
  • Regulate fluid and electrolyte balance. Monitor weight closely.
  • Dietary modification if severe kidney dysfunction, e.g. restrict salt, protein, potassium and phosphate intake.
  • Avoid potential nephrotoxins: e.g. NSAIDs, aminoglycosides.

MEDICINE TREATMENT

Fluid overload

  • Furosemide, as a slow IV bolus, 80 mg.
    • Avoid unnecessary intravenous fluids.

If hypertension present: I12.0/I12.9

Diastolic BP >100 mmHg or systolic BP >150 mmHg:

  • Amlodipine, oral, 5 mg as a single dose.

AND

  • Furosemide, oral, 40–80 mg (if eGFR <30 mL/min/1.73m2).

OR

  • Hydrochlorothiazide, oral, 25 mg (if eGFR ≥30 mL/min/1.73m2).

Check all medicines for possible dose adjustments. https://www.globalrph.com/index_renal.htm   

CONSULTATION/REFERRAL

The management of glomerular disease is individualised and management of all patients should be discussed with a specialist.

Click here to access the pdf.


Standard Treatment Guidelines and Essential Medicines List for South Africa, Adult Hospital Level, 2020-2024_Version 1.0_17 October 2024

Chapter 7 Nephrology/Urological Disorders_7.1 Nephrology Disorders_7.1.2 Glomerular Disease and Nephritic Syndrome

Drugs mentioned

ICD-10 codes

NeoHealth® ID 18346 · updated 7/9/2025